Trinity Biotech (TRIB) has released an update.
Trinity Biotech plc has entered into an agreement with Craig-Hallum Capital Group LLC, outlining terms for the at-the-market offering of American Depositary Shares (ADSs), which represent the company’s A Ordinary Shares. The agreement specifies the conditions under which Trinity Biotech will issue and sell its securities through Craig-Hallum, indicating a maximum number of shares available for sale based on several outlined criteria. This strategic financial move aims to enhance the company’s capital through periodic sales of its shares in the open market.
For further insights into TRIB stock, check out TipRanks’ Stock Analysis page.
